Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioEBIT MarginEBITDA MarginEBT MarginEnterprise ValueFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on Invested CapitalReturn on SalesTimes Interest Earned

Ascendis Pharma A (ASND) Invested Capital (2016 - 2025)

Historic Invested Capital for Ascendis Pharma A (ASND) over the last 14 years, with Q3 2025 value amounting to $273.3 million.

  • Ascendis Pharma A's Invested Capital rose 4781.38% to $273.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $853.0 million, marking a year-over-year increase of 2691.13%. This contributed to the annual value of $812.7 million for FY2024, which is 5150.9% up from last year.
  • According to the latest figures from Q3 2025, Ascendis Pharma A's Invested Capital is $273.3 million, which was up 4781.38% from $211.2 million recorded in Q2 2025.
  • In the past 5 years, Ascendis Pharma A's Invested Capital registered a high of $1.2 billion during Q3 2021, and its lowest value of $94.1 million during Q2 2023.
  • In the last 5 years, Ascendis Pharma A's Invested Capital had a median value of $536.4 million in 2023 and averaged $528.7 million.
  • As far as peak fluctuations go, Ascendis Pharma A's Invested Capital tumbled by 8758.15% in 2023, and later surged by 8209.27% in 2024.
  • Ascendis Pharma A's Invested Capital (Quarter) stood at $1.1 billion in 2021, then plummeted by 30.38% to $787.4 million in 2022, then tumbled by 31.87% to $536.4 million in 2023, then surged by 49.59% to $802.4 million in 2024, then plummeted by 65.94% to $273.3 million in 2025.
  • Its Invested Capital stands at $273.3 million for Q3 2025, versus $211.2 million for Q2 2025 and $183.6 million for Q1 2025.